| (+)-alpha-tocopherol | increases expression | ISO | RGD:1346665 | 6480464 | alpha-Tocopherol analog results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:20686688 |
| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; more ... | CTD | PMID:20686688 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of TNFRSF10B mRNA | CTD | PMID:14623915 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21167638 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1317581 | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TNFRSF10B mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21167638 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:14718643 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21167638 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317581 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | CTD | PMID:19520675 |
| 2-acetamidofluorene | increases expression | ISO | RGD:1317581 | 6480464 | 2-Acetylaminofluorene results in increased expression of TNFRSF10B mRNA | CTD | PMID:21607683 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:1317581 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of TNFRSF10B mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:1346665 | 6480464 | Fenretinide promotes the reaction [DDIT3 protein results in increased expression of TNFRSF10B mRNA] | CTD | PMID:17273769 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1346665 | 6480464 | Fenretinide results in increased expression of TNFRSF10B protein | CTD | PMID:15735044 PMID:17273769 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1346665 | 6480464 | Fenretinide results in increased expression of TNFRSF10B protein | CTD | PMID:17273769 PMID:15735044 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1346665 | 6480464 | Fenretinide results in increased expression of TNFRSF10B mRNA | CTD | PMID:17273769 |
| 4-tert-butylphenol | increases expression | ISO | RGD:1346665 | 6480464 | butylphen results in increased expression of TNFRSF10B protein | CTD | PMID:15816839 |
| 5-fluorouracil | increases response to substance | ISO | RGD:1317581 | 6480464 | TNFRSF10B protein results in increased susceptibility to Fluorouracil | CTD | PMID:15374982 |
| 5-fluorouracil | increases expression | ISO | RGD:1346665 | 6480464 | Fluorouracil results in increased expression of TNFRSF10B protein | CTD | PMID:15585621 |
| 5-fluorouracil | increases expression | ISO | RGD:1346665 | 6480464 | Fluorouracil results in increased expression of TNFRSF10B mRNA | CTD | PMID:17982676 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1346665 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFRSF10B mRNA] | CTD | PMID:17982676 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:1346665 | 6480464 | alitretinoin results in increased expression of TNFRSF10B mRNA | CTD | PMID:16449964 |
| acetylsalicylic acid | decreases response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein results in decreased susceptibility to Aspirin | CTD | PMID:18483385 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Azoxymethane results in increased expression of TNFRSF10B mRNA] | CTD | PMID:20043115 |
| acetylsalicylic acid | increases expression | ISO | RGD:1346665 | 6480464 | Aspirin results in increased expression of TNFRSF10B mRNA | CTD | PMID:20457246 |
| actinomycin D | decreases expression | ISO | RGD:1346665 | 6480464 | Dactinomycin results in decreased expression of TNFRSF10B mRNA | CTD | PMID:15572759 |
| actinomycin D | multiple interactions | ISO | RGD:1346665 | 6480464 | Dactinomycin inhibits the reaction [celecoxib results in increased expression of TNFRSF10B mRNA] | CTD | PMID:15572759 |
| aflatoxin B1 | increases expression | ISO | RGD:1317581 | 6480464 | Aflatoxin B1 results in increased expression of TNFRSF10B mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:1346665 | 6480464 | Aflatoxin B1 results in increased expression of TNFRSF10B mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1346665 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA | CTD | PMID:20349282 |
| amiodarone | increases expression | ISO | RGD:1346665 | 6480464 | [Amiodarone results in increased expression of DDIT3 mRNA] which results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:21292685 |
| amiodarone | multiple interactions | ISO | RGD:1346665 | 6480464 | DDIT3 mutant form inhibits the reaction [Amiodarone results in increased expression of TNFRSF10B]; more ... | CTD | PMID:21292685 |
| arsenic atom | multiple interactions | ISO | RGD:1346665 | 6480464 | [Arsenic co-treated with Fluorides] results in increased expression of TNFRSF10B mRNA | CTD | PMID:19962721 |
| arsenite(3-) | increases expression | ISO | RGD:1346665 | 6480464 | arsenite results in increased expression of TNFRSF10B mRNA | CTD | PMID:18585952 |
| arsenite(3-) | multiple interactions | ISO | RGD:1346665 | 6480464 | XPA protein affects the reaction [arsenite results in increased expression of TNFRSF10B mRNA] | CTD | PMID:18585952 |
| benzo[a]pyrene | increases expression | ISO | RGD:1346665 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1317581 | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | increases expression | ISO | RGD:1317581 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:15034205 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1317581 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1346665 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1346665 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:20064835 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1317581 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1317581 | 6480464 | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1317581 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of TNFRSF10B mRNA | CTD | PMID:21715664 |
| bepridil | increases expression | ISO | RGD:1346665 | 6480464 | Bepridil results in increased expression of TNFRSF10B protein | CTD | PMID:21292685 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1317581 | 6480464 | Mustard Gas results in increased expression of TNFRSF10B mRNA | CTD | PMID:18955075 |
| brefeldin A | multiple interactions | ISO | RGD:1346665 | 6480464 | Brefeldin A inhibits the reaction [bortezomib results in increased localization of TNFRSF10B protein] | CTD | PMID:17326159 |
| bupropion | increases expression | ISO | RGD:1346665 | 6480464 | Bupropion results in increased expression of TNFRSF10B mRNA | CTD | PMID:21354251 |
| cadmium atom | increases expression | ISO | RGD:1317581 | 6480464 | Cadmium results in increased expression of TNFRSF10B mRNA | CTD | PMID:22666406 |
| cadmium dichloride | increases expression | ISO | RGD:1346665 | 6480464 | Cadmium Chloride results in increased expression of TNFRSF10B mRNA | CTD | PMID:12160620 |
| capsaicin | increases expression | ISO | RGD:1346665 | 6480464 | Capsaicin results in increased expression of TNFRSF10B mRNA | CTD | PMID:19502594 PMID:19939880 |
| capsaicin | increases expression | ISO | RGD:1346665 | 6480464 | Capsaicin results in increased expression of TNFRSF10B mRNA | CTD | PMID:19502594 |
| capsaicin | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFRSF10B mutant form inhibits the reaction [Capsaicin results in increased susceptibility to TNFSF10 protein] | CTD | PMID:19939880 |
| capsaicin | increases expression | ISO | RGD:1346665 | 6480464 | Capsaicin results in increased expression of TNFRSF10B protein | CTD | PMID:19939880 |
| celastrol | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein promotes the reaction [[TNFSF10 protein co-treated with tripterine] results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20605676 |
| celastrol | increases expression | ISO | RGD:1346665 | 6480464 | tripterine results in increased expression of TNFRSF10B mRNA | CTD | PMID:20605676 |
| celecoxib | increases expression | ISO | RGD:1346665 | 6480464 | celecoxib results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:15572759 |
| celecoxib | affects response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B affects the susceptibility to celecoxib | CTD | PMID:15572759 |
| celecoxib | multiple interactions | ISO | RGD:1346665 | 6480464 | Cycloheximide promotes the reaction [celecoxib results in increased expression of TNFRSF10B protein]; more ... | CTD | PMID:15572759 |
| chlorambucil | affects expression | ISO | RGD:1346665 | 6480464 | Chlorambucil affects the expression of TNFRSF10B protein | CTD | PMID:14614459 |
| chlorambucil | increases expression | ISO | RGD:1346665 | 6480464 | Chlorambucil results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:18092340 |
| choline | multiple interactions | ISO | RGD:1317581 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TNFRSF10B; more ... | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1346665 | 6480464 | [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:21214929 |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21037225 more ... |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B mRNA | CTD | PMID:20623264 more ... |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21532991 more ... |
| cisplatin | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFSF10 protein promotes the reaction [Cisplatin results in increased expression of TNFRSF10B mRNA]; more ... | CTD | PMID:20623264 |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B protein | CTD | PMID:20623264 |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21037225 more ... |
| cisplatin | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein promotes the reaction [Cisplatin results in increased susceptibility to TNFSF10 protein] | CTD | PMID:21152876 |
| cisplatin | increases expression | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of TNFRSF10B mRNA | CTD | PMID:21532991 PMID:21037225 |
| cisplatin | multiple interactions | ISO | RGD:1346665 | 6480464 | Cisplatin results in increased expression of and results in increased localization of TNFRSF10B protein | CTD | PMID:21037225 |
| cobalt atom | multiple interactions | ISO | RGD:1346665 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of TNFRSF10B mRNA | CTD | PMID:18078969 |
| cobalt dichloride | affects expression | ISO | RGD:1346665 | 6480464 | cobaltous chloride affects the expression of TNFRSF10B mRNA alternative form | CTD | PMID:19320972 |
| cobalt dichloride | increases expression | ISO | RGD:1346665 | 6480464 | cobaltous chloride results in increased expression of TNFRSF10B mRNA | CTD | PMID:19376846 |
| cobalt dichloride | multiple interactions | ISO | RGD:1346665 | 6480464 | cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mRNA]] | CTD | PMID:19714248 PMID:19714248 |
| cocaine | affects expression | ISO | RGD:1317581 | 6480464 | Cocaine affects the expression of TNFRSF10B mRNA | CTD | PMID:15681117 |
| copper atom | multiple interactions | ISO | RGD:1346665 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TNFRSF10B mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1346665 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TNFRSF10B mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:1346665 | 6480464 | Copper Sulfate results in increased expression of TNFRSF10B mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | increases expression | ISO | RGD:1346665 | 6480464 | Asbestos, Crocidolite results in increased expression of TNFRSF10B mRNA | CTD | PMID:18687144 |
| curcumin | decreases expression | ISO | RGD:1346665 | 6480464 | Curcumin results in decreased expression of TNFRSF10B mRNA | CTD | PMID:16101141 |
| curcumin | increases expression | ISO | RGD:1346665 | 6480464 | Curcumin results in increased expression of TNFRSF10B protein | CTD | PMID:16613838 more ... |
| curcumin | increases expression | ISO | RGD:1346665 | 6480464 | Curcumin results in increased expression of TNFRSF10B protein | CTD | PMID:18226269 more ... |
| curcumin | increases expression | ISO | RGD:1346665 | 6480464 | Curcumin results in increased expression of TNFRSF10B protein | CTD | PMID:16613838 more ... |
| curcumin | increases expression | ISO | RGD:1346665 | 6480464 | Curcumin analog results in increased expression of TNFRSF10B protein | CTD | PMID:20599780 |
| curcumin | multiple interactions | ISO | RGD:1346665 | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of TNFRSF10B protein] | CTD | PMID:18226269 |
| curcumin | increases response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein results in increased susceptibility to Curcumin | CTD | PMID:16613838 |
| curcumin | increases expression | ISO | RGD:1346665 | 6480464 | Curcumin results in increased expression of TNFRSF10B protein | CTD | PMID:18226269 PMID:16613838 |
| cycloheximide | multiple interactions | ISO | RGD:1346665 | 6480464 | Cycloheximide promotes the reaction [celecoxib results in increased expression of TNFRSF10B protein] | CTD | PMID:15572759 |
| cycloheximide | multiple interactions | ISO | RGD:1346665 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide] | CTD | PMID:18222423 |
| cycloheximide | multiple interactions | ISO | RGD:1346665 | 6480464 | Cycloheximide inhibits the reaction [Paclitaxel results in increased expression of TNFRSF10B protein]; more ... | CTD | PMID:11212279 |
| cycloheximide | increases expression | ISO | RGD:1346665 | 6480464 | Cycloheximide results in increased expression of TNFRSF10B mRNA | CTD | PMID:15572759 |
| cyclosporin A | increases expression | ISO | RGD:1346665 | 6480464 | Cyclosporine results in increased expression of TNFRSF10B mRNA | CTD | PMID:20106945 |
| cytarabine | multiple interactions | ISO | RGD:1346665 | 6480464 | Cytarabine promotes the reaction [TNFSF10 protein results in increased expression of TNFRSF10B protein] | CTD | PMID:18549619 |
| cytarabine | increases expression | ISO | RGD:1346665 | 6480464 | Cytarabine results in increased expression of TNFRSF10B protein | CTD | PMID:18549619 |
| daunorubicin | multiple interactions | ISO | RGD:1346665 | 6480464 | Daunorubicin promotes the reaction [TNFSF10 results in increased expression of TNFRSF10B mRNA] | CTD | PMID:17204177 |
| diarsenic trioxide | increases expression | ISO | RGD:1346665 | 6480464 | arsenic trioxide results in increased expression of TNFRSF10B | CTD | PMID:19939880 |
| diarsenic trioxide | increases expression | ISO | RGD:1346665 | 6480464 | arsenic trioxide results in increased expression of TNFRSF10B protein | CTD | PMID:12851490 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1346665 | 6480464 | arsenic trioxide results in increased expression of TNFRSF10B protein | CTD | PMID:12851490 PMID:18172319 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346665 | 6480464 | TP53 protein affects the reaction [arsenic trioxide results in increased expression of TNFRSF10B protein] | CTD | PMID:12851490 |
| diarsenic trioxide | affects response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B affects the susceptibility to arsenic trioxide | CTD | PMID:18172319 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346665 | 6480464 | DDIT3 mutant form inhibits the reaction [arsenic trioxide results in increased expression of TNFRSF10B protein] | CTD | PMID:18172319 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346665 | 6480464 | bortezomib promotes the reaction [arsenic trioxide results in increased activity of TNFRSF10B] | CTD | PMID:20471514 |
| diarsenic trioxide | increases expression | ISO | RGD:1346665 | 6480464 | arsenic trioxide results in increased expression of TNFRSF10B protein | CTD | PMID:18172319 PMID:12851490 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346665 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[arsenic trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein] | CTD | PMID:17145888 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346665 | 6480464 | DDIT3 affects the reaction [arsenic trioxide results in increased expression of TNFRSF10B] | CTD | PMID:19939880 |
| docebenone | increases expression | ISO | RGD:1346665 | 6480464 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in increased expression of TNFRSF10B protein | CTD | PMID:17645780 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:1346665 | 6480464 | Cycloheximide inhibits the reaction [docetaxel results in increased expression of TNFRSF10B protein] | CTD | PMID:11212279 |
| docetaxel anhydrous | increases expression | ISO | RGD:1346665 | 6480464 | docetaxel results in increased expression of TNFRSF10B protein | CTD | PMID:11212279 |
| doxorubicin | multiple interactions | ISO | RGD:1346665 | 6480464 | [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein; more ... | CTD | PMID:21214929 |
| doxorubicin | multiple interactions | ISO | RGD:1346665 | 6480464 | Doxorubicin promotes the reaction [PARP1 protein binds to TNFRSF10B promoter] | CTD | PMID:19714248 |
| doxorubicin | multiple interactions | ISO | RGD:1346665 | 6480464 | cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mRNA]] | CTD | PMID:19714248 PMID:19714248 |
| doxorubicin | affects response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein affects the susceptibility to Doxorubicin | CTD | PMID:16098063 PMID:17922852 |
| doxorubicin | increases expression | ISO | RGD:1346665 | 6480464 | Doxorubicin results in increased expression of TNFRSF10B protein | CTD | PMID:17922852 PMID:15897917 |
| doxorubicin | increases expression | ISO | RGD:1346665 | 6480464 | Doxorubicin results in increased expression of TNFRSF10B mRNA | CTD | PMID:16705698 PMID:17922852 |
| doxorubicin | affects response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B protein affects the susceptibility to Doxorubicin | CTD | PMID:17922852 PMID:16098063 |
| doxorubicin | increases expression | ISO | RGD:1317581 | 6480464 | Doxorubicin results in increased expression of TNFRSF10B mRNA | CTD | PMID:16243910 |
| doxorubicin | increases expression | ISO | RGD:1346665 | 6480464 | Doxorubicin results in increased expression of TNFRSF10B protein | CTD | PMID:15897917 PMID:17922852 |
| doxorubicin | increases expression | ISO | RGD:1346665 | 6480464 | Doxorubicin results in increased expression of TNFRSF10B mRNA | CTD | PMID:17922852 PMID:16705698 |
| elemental selenium | increases expression | ISO | RGD:1346665 | 6480464 | Selenium results in increased expression of TNFRSF10B protein | CTD | PMID:12432279 |
| epichlorohydrin | increases expression | ISO | RGD:1346665 | 6480464 | Epichlorohydrin results in increased expression of TNFRSF10B mRNA | CTD | PMID:22723965 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:1346665 | 6480464 | Egtazic Acid inhibits the reaction [Amiodarone results in increased expression of TNFRSF10B] | CTD | PMID:21292685 |
| etoposide | multiple interactions | ISO | RGD:1346665 | 6480464 | Etoposide promotes the reaction [TP53 protein binds to TNFRSF10B promoter] | CTD | PMID:15964798 |
| etoposide | increases expression | ISO | RGD:1346665 | 6480464 | Etoposide results in increased expression of TNFRSF10B mRNA | CTD | PMID:15964798 |
| folic acid | affects expression | ISO | RGD:1346665 | 6480464 | Folic Acid affects the expression of TNFRSF10B mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:1317581 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF10B gene; more ... | CTD | PMID:20938992 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of TNFRSF10B mRNA | CTD | PMID:22079235 |
| genistein | decreases expression | ISO | RGD:1346665 | 6480464 | Genistein results in decreased expression of TNFRSF10B mRNA | CTD | PMID:16705744 |
| glutathione | multiple interactions | ISO | RGD:1346665 | 6480464 | Glutathione inhibits the reaction [rosiglitazone results in increased expression of TNFRSF10B protein] | CTD | PMID:18164688 |
| hydrogen peroxide | increases expression | ISO | RGD:1346665 | 6480464 | Hydrogen Peroxide results in increased expression of TNFRSF10B | CTD | PMID:18687144 |
| hydroquinone | decreases expression | ISO | RGD:1346665 | 6480464 | hydroquinone results in decreased expression of TNFRSF10B mRNA | CTD | PMID:15452088 |
| hydroxyurea | increases expression | ISO | RGD:1346665 | 6480464 | Hydroxyurea results in increased expression of TNFRSF10B mRNA | CTD | PMID:18647660 |
| imatinib | increases expression | ISO | RGD:1346665 | 6480464 | imatinib results in increased expression of TNFRSF10B mRNA | CTD | PMID:21935477 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of TNFRSF10B mRNA | CTD | PMID:16978161 |
| L-methionine | multiple interactions | ISO | RGD:1317581 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:20938992 |
| leptomycin B | increases expression | ISO | RGD:1346665 | 6480464 | leptomycin B results in increased expression of TNFRSF10B mRNA | CTD | PMID:20803015 |
| LY294002 | increases expression | ISO | RGD:1346665 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B | CTD | PMID:15942663 |
| LY294002 | multiple interactions | ISO | RGD:1346665 | 6480464 | resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein] | CTD | PMID:21179458 |
| LY294002 | increases expression | ISO | RGD:1346665 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein | CTD | PMID:16434995 PMID:21179458 |
| LY294002 | increases expression | ISO | RGD:1346665 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein | CTD | PMID:16434995 |
| methotrexate | increases expression | ISO | RGD:1346665 | 6480464 | Methotrexate results in increased expression of TNFRSF10B protein | CTD | PMID:17637740 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1346665 | 6480464 | Acetylcysteine inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B] | CTD | PMID:21362627 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1346665 | 6480464 | Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of TNFRSF10B protein] | CTD | PMID:21741372 |
| N-nitrosodiethylamine | decreases response to substance | ISO | RGD:1317581 | 6480464 | TNFRSF10B protein results in decreased susceptibility to Diethylnitrosamine | CTD | PMID:18079962 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1317581 | 6480464 | Diethylnitrosamine results in increased expression of TNFRSF10B mRNA | CTD | PMID:21607683 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:1346665 | 6480464 | Dimethylnitrosamine results in increased expression of TNFRSF10B protein | CTD | PMID:17849272 |
| paclitaxel | increases expression | ISO | RGD:1346665 | 6480464 | Paclitaxel results in increased expression of TNFRSF10B protein | CTD | PMID:11212279 |
| paclitaxel | multiple interactions | ISO | RGD:1346665 | 6480464 | Cycloheximide inhibits the reaction [Paclitaxel results in increased expression of TNFRSF10B protein] | CTD | PMID:11212279 |
| paracetamol | increases expression | ISO | RGD:1346665 | 6480464 | Acetaminophen results in increased expression of TNFRSF10B mRNA | CTD | PMID:22230336 |
| paraquat | increases expression | ISO | RGD:1346665 | 6480464 | Paraquat results in increased expression of TNFRSF10B mRNA | CTD | PMID:18836921 |
| pemetrexed | multiple interactions | ISO | RGD:1346665 | 6480464 | DDIT3 mutant form inhibits the reaction [pemetrexed results in increased expression of TNFRSF10B] | CTD | PMID:21726997 |
| pemetrexed | increases expression | ISO | RGD:1346665 | 6480464 | pemetrexed results in increased expression of TNFRSF10B | CTD | PMID:21726997 |
| pentobarbital | decreases expression | EXP | | 6480464 | Pentobarbital results in decreased expression of TNFRSF10B mRNA | CTD | PMID:16978161 |
| quercetin | multiple interactions | ISO | RGD:1346665 | 6480464 | mithramycin A inhibits the reaction [Quercetin results in increased expression of TNFRSF10B mRNA]; more ... | CTD | PMID:18980244 |
| quercetin | increases expression | ISO | RGD:1346665 | 6480464 | Quercetin results in increased expression of TNFRSF10B mRNA | CTD | PMID:18980244 PMID:21632981 |
| quercetin | increases expression | ISO | RGD:1346665 | 6480464 | Quercetin results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:18980244 |
| quercetin | affects localization | ISO | RGD:1346665 | 6480464 | Quercetin affects the localization of TNFRSF10B protein | CTD | PMID:17876056 |
| quercetin | multiple interactions | ISO | RGD:1346665 | 6480464 | Nystatin inhibits the reaction [Quercetin affects the localization of TNFRSF10B protein]; more ... | CTD | PMID:17876056 |
| resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 |
| resveratrol | multiple interactions | ISO | RGD:1346665 | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein]; more ... | CTD | PMID:21179458 |
| resveratrol | increases localization | ISO | RGD:1346665 | 6480464 | resveratrol results in increased localization of TNFRSF10B protein | CTD | PMID:19561642 |
| resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 more ... |
| resveratrol | multiple interactions | ISO | RGD:1346665 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with resveratrol] | CTD | PMID:18222423 |
| resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 PMID:21209944 |
| resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B mRNA | CTD | PMID:12569576 |
| rosiglitazone | multiple interactions | ISO | RGD:1346665 | 6480464 | Glutathione inhibits the reaction [rosiglitazone results in increased expression of TNFRSF10B protein] | CTD | PMID:18164688 |
| rosiglitazone | increases expression | ISO | RGD:1346665 | 6480464 | rosiglitazone results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:18164688 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:1346665 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[arsenic trioxide co-treated with Buthionine Sulfoximine] results in increased expression of TNFRSF10B protein] | CTD | PMID:17145888 |
| selenium atom | increases expression | ISO | RGD:1346665 | 6480464 | Selenium results in increased expression of TNFRSF10B protein | CTD | PMID:12432279 |
| silibinin | multiple interactions | ISO | RGD:1346665 | 6480464 | DDIT3 affects the reaction [silybin results in increased expression of TNFRSF10B] | CTD | PMID:19939880 |
| silibinin | increases expression | ISO | RGD:1346665 | 6480464 | silybin results in increased expression of TNFRSF10B | CTD | PMID:19939880 |
| sulindac | increases expression | ISO | RGD:1346665 | 6480464 | Sulindac results in increased expression of TNFRSF10B protein | CTD | PMID:15572759 |
| thalidomide | decreases expression | ISO | RGD:1346665 | 6480464 | Thalidomide results in decreased expression of TNFRSF10B protein | CTD | PMID:16531263 |
| trans-resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346665 | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein]; more ... | CTD | PMID:21179458 |
| trans-resveratrol | increases localization | ISO | RGD:1346665 | 6480464 | resveratrol results in increased localization of TNFRSF10B protein | CTD | PMID:19561642 |
| trans-resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:1346665 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with resveratrol] | CTD | PMID:18222423 |
| trans-resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B protein | CTD | PMID:17636462 PMID:21209944 |
| trans-resveratrol | increases expression | ISO | RGD:1346665 | 6480464 | resveratrol results in increased expression of TNFRSF10B mRNA | CTD | PMID:12569576 |
| trichostatin A | increases expression | ISO | RGD:1346665 | 6480464 | trichostatin A results in increased expression of TNFRSF10B mRNA; more ... | CTD | PMID:15964798 |
| trichostatin A | multiple interactions | ISO | RGD:1346665 | 6480464 | [Plant Extracts co-treated with trichostatin A] results in increased expression of TNFRSF10B protein | CTD | PMID:18709356 |
| troglitazone | increases expression | ISO | RGD:1346665 | 6480464 | troglitazone results in increased expression of TNFRSF10B protein | CTD | PMID:16820965 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:1346665 | 6480464 | Acetylcysteine inhibits the reaction [Ursodeoxycholic Acid results in increased expression of TNFRSF10B]; more ... | CTD | PMID:21362627 |
| ursodeoxycholic acid | increases response to substance | ISO | RGD:1346665 | 6480464 | TNFRSF10B results in increased susceptibility to Ursodeoxycholic Acid | CTD | PMID:21362627 |
| ursodeoxycholic acid | increases expression | ISO | RGD:1346665 | 6480464 | Ursodeoxycholic Acid results in increased expression of TNFRSF10B protein; more ... | CTD | PMID:21362627 |
| valproic acid | increases expression | ISO | RGD:1346665 | 6480464 | Valproic Acid results in increased expression of TNFRSF10B mRNA | CTD | PMID:15964798 |
| zinc atom | multiple interactions | ISO | RGD:1346665 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF10B mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1346665 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF10B mRNA | CTD | PMID:18593933 |
| zoledronic acid | multiple interactions | ISO | RGD:1346665 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA | CTD | PMID:20349282 |